Valneva SE (VALN) Net Shares Issued and Repurchased (2019 - 2021)
Valneva SE (VALN) posted Net Shares Issued and Repurchased of $1.1 million for Q1 2026, down 84.93% sequentially from $7.1 million in Q3 2025.
Analysis
Valneva SE (VALN) Net Shares Issued and Repurchased (2019 - 2021) Analysis & Trends
Valneva SE has reported Net Shares Issued and Repurchased for 6 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Net Shares Issued and Repurchased changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 million (down 50.58% YoY) and the FY2024 annual result came in at $61.8 million, up 23921.58% from the prior year.
- Net Shares Issued and Repurchased retreated to $1.1 million in Q1 2026 per VALN's latest filing, from $7.1 million in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $310.0 million in Q3 2023 and troughed at -$310.1 million in Q2 2023.
- A 5-year average of $31.9 million and a median of $7.1 million in 2025 frame the typical range for Net Shares Issued and Repurchased.
- The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased slumped 79.64% in 2024, then sank 88.68% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $193.7 million in 2022, then surged by 60.05% to $310.0 million in 2023, then slumped by 100.11% to -$343019.1 in 2024, then jumped by 2183.05% to $7.1 million in 2025, then sank by 84.93% to $1.1 million in 2026.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.1 million, $7.1 million, and $22.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 239,089.93 |
| Sep 30, 2021 | 246,471.05 |
| Dec 31, 2020 | 256,342.32 |
| Dec 31, 2019 | 23,244.64 |